IGF2BP1 and colorectal carcinoma: We demonstrated that RBM15/IGF2BP1-mediated m6A modification of MEF2A upregulated its expression to promote PD-L1 transcription, which stabilized SOX12 mRNA and then weakened cetuximab sensitivity in CRC.